By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Clontech Laboratories and Tet Systems said today they have expanded an existing licensing agreement to grant Clontech rights to develop, manufacture, and commercialize novel Tet products, including the Tet-On 3G Inducible Expression System.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.